Fund III (2006)

Vibrynt

Vibrynt developed a minimally-invasive procedure for delivery of a novel implant for the treatment of obesity.

Vibrynt’s Prevail™ is a saline-filled expandable balloon implanted above the stomach in the abdominal cavity that restricts the expansion of the stomach.